Pfizer and PepsiCo emerge as dividend stock opportunities
PEP PepsiCo Inc
$139.00 -2.02%
View chart & analysis → - 1Pfizer recorded $16.6 billion in revenue last quarter.
- 2PepsiCo's North American beverage sales volume decreased 2% year-over-year last quarter.
- 3As dividend stocks are being overlooked by investors, Pfizer and PepsiCo may offer good buying opportunities.
So what's the key point?
Pfizer generated $16.6 billion in revenue, while PepsiCo saw a decline in beverage sales. With interest in dividend-paying stocks fading, it may be a good time to buy these two companies.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.